Hoitt Jason

Chief Patient Officer at STOK; Chief Commercial Officer at Provention Bio, Inc.; Chief Commercial Officer at Dova Pharmaceuticals Inc.

Sold, on record
$401k
Dollars the filings state
Form 4 sales
6
Latest Mar 18, 2026
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Dova Pharmaceuticals Inc.Plan not stated
    Apr 8, 2019 2019

    Sold 2,387 shares at $8.77 ($21k)

    Hoitt Jason, Chief Commercial Officer

    Sold 9.7% of holdings ($217k position)22,324 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Dova Pharmaceuticals Inc.Plan not stated
    Jun 28, 2019 +81 days

    Sold 2,387 shares at $13.81 ($33k)

    Hoitt Jason, Chief Commercial Officer

    Sold 10.7% of holdings ($308k position)19,937 shares leftFiling

  3. 3 Form 4 sale Dova Pharmaceuticals Inc.Unusual
    Jul 15, 2019 +17 days

    Sold 7,580 shares at $15.26 ($116k)

    Hoitt Jason, Chief Commercial Officer

    Sold 38% of holdings ($304k position)12,357 shares leftFiling

  4. 4 Form 4 sale Dova Pharmaceuticals Inc.Plan not stated
    Sep 30, 2019 +77 days

    Sold 2,387 shares at $28.00 ($67k)

    Hoitt Jason, Chief Commercial Officer

    Sold 19.3% of holdings ($346k position)9,970 shares left1x usual sizeFiling

  5. 5 Form 4 sale Provention Bio, Inc.Unusual
    Feb 10, 2023 +1229 days

    Sold 4,500 shares at $10.00 ($45k)

    Hoitt Jason, Chief Commercial Officer

    Sold 100% of holdings ($45k position)0 shares leftFirst sale on recordFiling

  6. 6 Form 4 sale STOKUnusual
    Mar 18, 2026 +1132 days

    Sold 3,712 shares at $32.14 ($119k)

    Hoitt Jason, Chief Patient Officer

    No 10b5-1 planSold 26.5% of holdings ($450k position)10,276 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (6)

Form 144 notices and Form 4 sales by Hoitt Jason
Source
Mar 18, 2026Mar 19, 2026STOKChief Patient OfficerForm 4 sale3,712$119k26.5%UnusualSEC
Feb 10, 2023Feb 14, 2023Provention Bio, Inc.Chief Commercial OfficerForm 4 sale4,500$45k100.0%UnusualSEC
Sep 30, 2019Oct 2, 2019Dova Pharmaceuticals Inc.Chief Commercial OfficerForm 4 sale2,387$67k19.3%Plan not statedSEC
Jul 15, 2019Jul 16, 2019Dova Pharmaceuticals Inc.Chief Commercial OfficerForm 4 sale7,580$116k38.0%UnusualSEC
Jun 28, 2019Jul 2, 2019Dova Pharmaceuticals Inc.Chief Commercial OfficerForm 4 sale2,387$33k10.7%Plan not statedSEC
Apr 8, 2019Apr 10, 2019Dova Pharmaceuticals Inc.Chief Commercial OfficerForm 4 sale2,387$21k9.7%Plan not statedSEC